Elucidata
Vivjan Myrto is the Founder and Managing Partner at Hyperplane, a position held since January 2015. Alongside this role, Vivjan serves as a Board Member for the Mass Technology Leadership Council and Butlr, effective from July 2024 and January 2022, respectively. Additionally, Vivjan has been a Board Director at ShipIn Systems, Modulate.ai, Greeneye Technology, and Elucidata since October 2020, February 2019, December 2018, and May 2018, respectively. In the capacity of Board Observer, Vivjan has contributed to MachineMetrics since January 2017 and was involved with Tive Inc until October 2023. Previously, Vivjan held the role of Board Director at Dexai Robotics until its acquisition by Sony in February 2024.
This person is not in any offices
Elucidata
5 followers
Elucidata offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolic disorders. Elucidata supports discovery programs at Pfizer, Agios Pharmaceuticals, Genentech, and Yale and has 35+ research partners from premier biopharma companies and research labs.